Disease Burden and Economic Impact
Disease burden and economic impact is the area of health economics concerned with quantifying how much disease costs a population — measured both in lost health (mortality, disability, and the years of healthy life they consume) and in money (the medical and non-medical resources used and the production foregone). It supplies the descriptive evidence that priority-setting, resource allocation, and cost-effectiveness analysis build upon.
Definition
Disease burden is the total impact of a health problem on a population, captured by health-loss measures (deaths, disability, and combined metrics such as DALYs) and by economic measures (direct, indirect, and intangible costs of illness).
Scope
The area gathers the metrics and methods used to express the size of a health problem in comparable terms: summary measures of population health such as the disability-adjusted life-year, cost-of-illness accounting that separates direct from indirect costs, the valuation of productivity loss, and applied estimates of the burden imposed by particular diseases. It is descriptive and methodological; it characterises how burden is measured rather than prescribing how individual patients should be managed.
Sub-topics
Core questions
- How can the health loss caused by different diseases be expressed on a single comparable scale?
- What does an illness cost — in health-care resources, in lost productivity, and in welfare?
- How do direct and indirect costs differ, and how should each be valued?
- How is the economic burden of a specific disease estimated, and how should such estimates be interpreted?
Key concepts
- Summary measures of population health
- Disability-adjusted life-year (DALY)
- Years of life lost and years lived with disability
- Cost of illness
- Direct, indirect, and intangible costs
- Productivity loss
- Prevalence-based versus incidence-based costing
Clinical relevance
Burden and cost estimates describe how a disease affects a population and the resources it consumes; they inform planning, advocacy, and the inputs to economic evaluation. They are population-level descriptive tools and do not direct the diagnosis or treatment of an individual patient.
Epidemiology
Comparative burden estimation was consolidated by the Global Burden of Disease enterprise, which combines mortality and disability across hundreds of conditions and many countries to rank causes of lost health and track them over time. Parallel economic work documents the rising share of national resources consumed by chronic and non-communicable diseases.
Evidence & guidelines
The Global Burden of Disease studies provide the most widely used comparative burden estimates, while cost-of-illness practice draws on health-economic methods texts and national costing studies. Estimates are sensitive to methodological choices, and transparent reporting of perspective, cost components, and valuation method is expected.
History
Modern comparative burden measurement grew from the original Global Burden of Disease Study of the 1990s, which introduced the DALY as a common currency for health loss, and from the parallel maturation of cost-of-illness methods in health economics. Successive GBD cycles extended coverage to hundreds of diseases and most of the world's countries.
Key figures
- Christopher Murray
- Alan Lopez
- Marc Koopmanschap
- Derek Yach
Related topics
Seminal works
- murray-1997
- murray-2013-nejm
- vos-2020
Frequently asked questions
- What is the difference between the health burden and the economic burden of a disease?
- The health burden expresses impact in lost health — deaths, disability, and combined measures such as DALYs — whereas the economic burden expresses impact in money: the resources used to treat the illness and the production lost because of it.
- Why measure disease burden at all?
- Common metrics let very different conditions be compared on one scale, which supports priority-setting, advocacy, and the descriptive inputs that economic evaluation needs; they describe the size of problems rather than telling clinicians how to treat individuals.